Serum Adiponectin in Elderly Men Does Not Correlate with Fracture Risk | Zendy

Karl Michaëlsson | Zendy; Lars Lind | Zendy; Jan Frystyk | Zendy; Allan Flyvbjerg | Zendy; Rolf Gedeborg | Zendy; Christian Berne | Zendy; Björn Zethelius | Zendy; Hans Mallmin | Zendy; Stefan Söderberg | Zendy; Håkan Melhus | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Adiponectin in Elderly Men Does Not Correlate with Fracture Risk

Author(s) -

Karl Michaëlsson,

Lars Lind,

Jan Frystyk,

Allan Flyvbjerg,

Rolf Gedeborg,

Christian Berne,

Björn Zethelius,

Hans Mallmin,

Stefan Söderberg,

Håkan Melhus

Publication year - 2008

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-0617

Subject(s) - adiponectin , medicine , bone mineral , prospective cohort study , hazard ratio , proportional hazards model , endocrinology , cohort study , cohort , osteoporosis , confidence interval , obesity , insulin resistance

Recent evidence suggests that adiponectin may play a role in bone metabolism, but studies of the correlation between serum adiponectin and bone mineral density (BMD) have given conflicting results, and the impact on fracture risk is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research